E. Orav

发表

Association of Practice-Level Social and Medical Risk With Performance in the Medicare Physician Value-Based Payment Modifier Program

E. Orav, A. Epstein, Lena M. Chen, 2017, JAMA.

Design and implementation of the North American Pediatric Cardiomyopathy Registry.

S. Colan, S. Osganian, J. Towbin, 2000, American heart journal.

Treating Children with Idiopathic Dilated Cardiomyopathy (from the Pediatric Cardiomyopathy Registry) in 40% of Children with Symptomatic Idiopathic Dilated Cardiomyopathy (idc), Medical Therapy Fails within 2 Years of Diagnosis. Strong Evidence-based Therapies Are Not Available for These Children,

S. Colan, J. Towbin, L. Sleeper, 2022 .

Echocardiographic Strain Imaging to Assess Early and Late Consequences of Sarcomere Mutations in Hypertrophic Cardiomyopathy

O. Havndrup, H. Bundgaard, M. Christiansen, 2009, Circulation. Cardiovascular genetics.

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy

L. Mestroni, S. Colan, J. Towbin, 2017, Open Heart.

Subtle Abnormalities in Contractile Function Are an Early Manifestation of Sarcomere Mutations in Dilated Cardiomyopathy

S. Colan, J. Seidman, E. Orav, 2012, Circulation. Cardiovascular genetics.

Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers

R. Levine, E. Orav, H. Bundgaard, 2018, European heart journal cardiovascular Imaging.

Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers Without Left Ventricular Hypertrophy

S. Colan, E. Orav, C. Macrae, 2013, Circulation. Cardiovascular genetics.

Measuring Efficiency: The Association Of Hospital Costs And Quality Of Care Are the goals of quality improvement and cost reduction complementary to or in competition with one another?

E. John Orav, Ashish K. Jha, Arnold M. Epstein, 2009 .

Meaningful Use of the Indian Health Service Electronic Health Record

Martha A. Palan, E. Orav, T. Sequist, 2017, Health services research.

Cardiac morbidity and related mortality in children with HIV infection.

E. Orav, S. Lipshultz, K. Mcintosh, 1993, JAMA.

Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia.

S. Lipsitz, S. Colan, J. Olsen, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

E J Orav, S R Lipsitz, S. Lipsitz, 1995, The New England journal of medicine.

Biomarkers of Vascular Dysfunction in Children Infected With Human Immunodeficiency Virus-1

E. Orav, S. Lipshultz, R. Goldberg, 2010, Journal of acquired immune deficiency syndromes.

Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry

S. Colan, J. Towbin, L. Sleeper, 2007, Circulation.

Incidence, causes, and outcomes of dilated cardiomyopathy in children.

S. Colan, J. Towbin, L. Sleeper, 2006, JAMA.

The incidence of pediatric cardiomyopathy in two regions of the United States.

E John Orav, Steven E Lipshultz, S. Colan, 2003, The New England journal of medicine.

Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial

Amit R. Patel, Akshay S. Desai, L. Mestroni, 2021, Nature Medicine.

Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine.

S. Colan, E. Orav, S. Lipshultz, 1992, The New England journal of medicine.

Evolution of hypertrophic cardiomyopathy in sarcomere mutation carriers

S. Colan, C. Semsarian, Carolyn Y. Ho, 2016, Heart.

The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years.

S. Colan, J. Towbin, L. Sleeper, 2010, Heart failure clinics.

Cardiac Dysfunction and Mortality in HIV-Infected Children: The Prospective P2C2 HIV Multicenter Study

S. Colan, E. Orav, S. Lipshultz, 2000, Circulation.